Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ).
Ab&B Bio-Tech CO., LTD. JS has announced the current composition of its board of directors, which includes three executive directors, three non-executive directors and three independent non-executive directors, with chairman An Youcai serving as head of the board. The company also detailed the membership and leadership of its four key board committees—audit, remuneration and appraisal, nomination, and strategy—highlighting the roles of independent directors as chairpersons of several committees, a structure that underscores its corporate governance framework and oversight arrangements for investors and other stakeholders.
More about Ab&B Bio-Tech CO., LTD. JS Class H
Ab&B Bio-Tech CO., LTD. JS is a biotechnology company based in the People’s Republic of China and listed in Hong Kong under stock code 2627. The company operates as a joint stock limited liability enterprise, though this announcement does not specify its particular biotech products, services, or market segments.
Average Trading Volume: 177,990
Technical Sentiment Signal: Strong Sell
Find detailed analytics on 2627 stock on TipRanks’ Stock Analysis page.